3 completed, 1 recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Bevacizumab: new trials by email Literature Review of Bevacizumab trials Research Report on Bevacizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases FSRT, HA-WBRT-SIB, Bevacizumab - Lung Adenocarcinoma, Brain Metastases | Phase 3 | Recruiting | Sun Yat-sen University | 220 | 2026-03-20 | 2026-04-06 |
| Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases Serplulimab combined with bevacizumab and first-line chemotherapy - Non-small Cell Lung Cancer Stage II, Bevacizumab | Phase 2 / Phase 3 | Completed | Sun Yat-sen University | 40 | 2023-05-14 | 2024-11-13 |
| Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer Pemetrexed/Platinum, Bevacizumab and Pemetrexed/platinum - Non Squamous Non-small Cell Lung Cancer, Brain Metastases | Phase 3 | Completed | Sun Yat-sen University | 160 | 2016-01-01 | 2025-08-17 |
| Topical Bevacizumab for Preventing Recurrent Pterygium bevacizumab eye drop 0.05%, normal saline 0.9% - Pterygium, Bevacizumab | Phase 3 | Completed | Chulalongkorn University | 24 | 2010-12-01 | 2013-04-09 |
Brain Neoplasms (3) · Adenocarcinoma of Lung (1) · Carcinoma, Non-Small-Cell Lung (1) · Pterygium (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Central Nervous System Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Lung Neoplasms (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Adenocarcinoma (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Conjunctival Diseases (1)
Bevacizumab (3) · Pemetrexed (1) · Platinum (1) · Saline Solution (1)
Sun Yat-sen University (3) · Chulalongkorn University (1)
China (3) · Thailand (1)
PMID 15254054, PMID 16757720, PMID 16856022, PMID 19801201, PMID 23814264, PMID 25349290, PMID 26409291, PMID 27458945, PMID 29420112, PMID 30395902, PMID 31569068, PMID 32058845, PMID 32347302